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OBJECTIVE: 
1. To study the immunohistochemical expression of CD10 in colorectal 
carcinoma and in premalignant lesion. 
2. To correlate the expression of CD10 in tumour cells and stromal cells with 
various clinico pathologic variables. 
INTRODUCTION: 
Continuous and bilateral molecular interaction between normal epithelial cells and 
stromal cells is disrupted by several factors  secreted by tumour cells  or by stromal 
cells under the influence of tumour cells. 
CD 10 is a matrix metalopeptidases involved in carcinogenesis through the release of 
bioactive molecules that stimulate invasion, extracellular matrix degradation, 
inhibition of apoptosis and promotion of angiogenesis and immune response 
modulation. 
MATERIAL AND METHODS: 
The study was conducted during the period of August 2016 to August 2017. It was 
carried out in specimens obtained from patients with confirmed histopathological 
diagnosis of colorectal adenomas and adenocarcinomas. The study was approved by 
the Ethical committee of Government  Stanley Medical College and hospital. 
STUDY DESIGN: Retrospective and comparative study. 
STUDY POPULATION:  
CASES:  The study sample comprised of 60 colorectal adenoma and adenocarcinoma 
patients. Cases were chosen from the Department of Surgical Gastroenterology, 
Department of Surgery, Government Stanley Medical College and hospital. Age, sex, 
tumor site, histological grade and tumor stage were obtained for all cases. All the 60 
cases were screened for CD 10 expression through immunohistochemical assay. 
INCLUSION CRITERIA: 
Patients with colorectal adenomas and adenocarcinomas. 
EXCLUSION CRITERIA: 
Chemotherapy and/or radiotherapy prior to sampling. 
Recurrent and metastatic adenocarcinomas. 
Cancer types other than adenocarcinomas. 
METHOD OF DATA COLLECTION: 
 A total of 60 cases, 30 each of colorectal adenoma and colorectal adenocarcinoma were 
studied at random and selected applying the inclusion and exclusion criteria. The tissues so 
obtained were processed and sectionswerecutat5microns.Hematoxylinand eosin stained   
sections  were  stained  and analysed. The clinico-pathological characteristics including age, 
sex, tumor site, histological diagnosis (Adenoma/adenocarcinoma),  histological grade 
(adenomas- low grade/high grade dysplasia ; adenocarcinoma – low/high) and 
adenocarcinoma stage were obtained for all the cases. 
METHODOFTISSUEPREPARATION: 
10% neutral buffered formalin was used for fixing the specimens. The tissues were 
processed in various grades of alcohol and xylene. Paraffin blocks were prepared and 
sections of 5 micron thickness were cut in semiautomatic microtome. Staining was 
done by haematoxylin and eosin. Suitable blocks were chosen for 
immunohistochemistry. 
IMMUNOHISTOCHEMICAL STAINING FOR CD 10: 
IHC was performed on the selected blocks for CD10 immunohistochemistry. Slides 
coated with chrome alum were used. Sections were subjected to antigen retrieval 
using pressure cooker technique using TRISEDTA (pH9.2) buffer solution and then 
treated by HRP (horseradish peroxidase) polymer technique. 
HRPPOLYMERTECHNIQUE 
The coated slides were taken through the following stages -   
1. Overnight incubation (first at 70 degree Celsius for one hour, the nat 40-45 
degree Celsius for overnight). 
2. Xylene-2 changes, 15 minutes each. 
3. Graded alcohol-first with absolute alcohol - 2 changes, 5 minutes each. Then 
for 3 minutes with 90% alcohol and finally for 3 minutes with 70% alcohol. 
4. Distilled water rinse for 2-5 minutes. 
5. Antigen retrieval with pressure cooker. 
6. Wash with tap water gradually. 
7. TRISbufferwashfor5minutes, 2changes. 
8. Treatment with peroxidase block–for inhibiting endogenous peroxidases in the 
tissue for10 minutes. 
9. TRIS buffer wash for 5 minutes, 2 changes. 
10. Application of primary antibody for 45 minutes. 
11. TRIS buffer wash for 5 minutes, 2 changes. 
12. Application of super enhancer for 15 minutes which enhances the final reaction 
product by increasing the sensitivity of antigen antibody reaction. 
13. TRIS buffer wash for 5 minutes, 2 changes. 
14. Application of secondary antibody from the goat with the tagged horseradish 
peroxidase enzyme for 15 minutes. 
15. TRIS buffer wash for 5 minutes, 2changes. 
16. Application  of  DAB  (Diaminobenzidine) chromogen  for  5  minutes  –this  is 
cleaved by the enzyme to give the colored product at the antigensites. 
17. Wash in distilled water for 5 minutes. 
18. The slides were counterstained with hematoxylin. 
19. Air dried, dehydrated, cleared and mounted with DPX (Distyrenedibutyl 
pthalidein Xylol). 
SCORING CRITERIA FOR CD10: Tumour CD10 was considered positive if more 
than 10% of tumour cells express fine to coarse cytoplasmic granules. Stromal CD10 
was graded according to a 4 point scale based on percentage of  positivily stained area. 
0- <10%positive tumour cells, 
     +1 -10-25%positive tumour cells, 
     +2 -25%-50%positive tumour cells, 
     +3 ->50%positive tumour cells, 
DISCUSSION: 
1. Age, gender and site distribution: 
The present study includes 60 cases which is comprised of 30 cases of colorectal 
adenomas and 30 cases of colorectal adenocarcinomas. The age group of patients 
included in the study varied from less than 20 years to more than 70 years with most 
of the patients being above 50 years of age. 40 %of the patients were males and 20 % 
were females. In  most of the patients, the tumor was located in the rectum (31.67%), 
followed by descending colon (25%), Ascending colon(18.33%) and Rectosigmoid 
junction (6.67%). 
2. Histological Type Distribution:  
Among the study participants,30(50.00%) were adenocarcinomas and 
30(50.00%)were adenomas. 
3. Carcinoma grade and stage distribution : 
          Out of the 30 adenocarcinomas that were studied, 10cases were well 
differentiated, 10 cases were moderately differentiated and 10 cases were poorly 
differentiated.  2 (6.67%) were stage I, 12 (40.00%) were stage II , 12 (40.00%) 
belonged to stage III and 4 (13.33%) were stage IV. 
4. Comparison of cd10expression with age : 
In present study (N=60) mean tumour and stromal CD 10 in different age group of 
people <50 yrs  and people >50 yrs were not statistically significant. 
Wang-et al in 2005observed in his study that comparison of CD 10 expression with 
age of the patient was statistically not significant Jang –et al also showed no 
correlation between CD10 expression and age of the patient. 
Iwase –et al also proved there was no statistical significance between CD 10 
Expression and age of the patient. 
5. Comparison of cd10 expression with gender: 
        In the present study, 40 patients (66.67%) were male and 20(33.33%) were 
female. Among the study participants, Mean TumourCD10 in male was  
48.78+−37.23  and   mean Tumour CD10 Median in female was 80.92-+25.66.The 
difference in between mean Tumour cd10 expression  and sex   is   statistically     
significant   (P Value 0.021). 
Wang et al and colleagues in their study conducted during 2005 found  significant 
correlation between CD 10 expression by the tumor and gender . 
          Koga et al also showed that CD 10expression by colorectal neoplasia did 
correlate with the gender. 
Conversely  Iwase et al.  in their  study concluded that no correlation existed between 
gender and CD 10 expression by colorectal adenomas and carcinomas . 
6. Tumour CD 10 Expression in  adenomasvs adenocarcinomas (The adenoma-
carcinoma sequence): 
         In the present study, cd 10 expression  gradually increased in adenomas from 
low grade dysplasia to high grade dysplasia and was maximally expressed in 
adenocarcinomas. The differences in mean CD 10 expression  between adenomas and 
adenocarcinomas was statistically significant (P value less than 0.001).  
This observation of gradually increased expression of CD10 in adenomas and 
Significantly increased expression in adenocarcinomas makes CD10  a potentially 
exploitable target of anti-cancer therapy with maximal targeting of the tumor and 
minimal damage to the normal epithelium. Also the significant increase observed  in 
CD10expression from  adenoma to adenocarcinoma suggests that CD 10 has an 
important role in colorectal tumorigenesis and malignant transformation of adenomas 
(the adenoma-carcinoma sequence).  
The mean  difference of  Tumour CD10 and stromal CD10 expression in subjects with 
carcinoma and adenoma was 41.41.It is statistically significant(p value 0.001). 
This result of the present study correlates with that of  Jang et al5 in 2013 stated that 
tumour CD 10 Expression significantly increased from 14% in low grade adenoma(3 
cases out of 22 cases),to 22% in high grade adenomas(6 cases out of 27 cases) and 
44% in invasive colorectal carcinoma(14 cases out of 32 cases) and this support the 
involvement of CD10 in progression and carcinogenesis of colorectal carcinoma. 
Wang et al63 in 2013 reported there was progression in tumour CD10 Expression from 
0.8%in low grade adenoma to 9.1% in high grade adenomas and 40% in invasive 
colorectal carcinoma. 
 Hirano et al7 in 2012, Koga et al64 in 2008, Iwase et al65 in 2005 also supported that 
CD 10 Expression were reported more frequently in invasive phenotype rather than 
adenomas.  
7. Comparison between Tumour and Stromal CD10 expression and the depth of 
tumour invasion: 
The present study includes 30 cases of colorectal adenocarcinomas of which , 10 were 
seen in T2 depth of tumour(Tumour invades muscularispropria), 11 were seen in T3 
depth of tumour (Tumour invades through the muscularispropria in to the 
pericolorectal tissue) and 9 were seen in T4 depth of tumour(Tumour penetrates the 
visceral peritoneum). 
The difference in between Tumour CD 10median and depth of invasion is  statistically 
significant (P value less than 0.001). A significant correlation is observed between 
Tumour and Stromal CD10 expression and depth of invasion. 
Hirano et al  reached similar conclusions in their  study on colorectal carcinomas 
which showed that CD 10 expression correlated significantly with depth of tumour 
invasion.The results of the present study are in agreement with, kogaet al who in their 
study conducted in 2008 comprising 48 cases of colorectal adenocarcinomas 
concluded that CD10expression correlated with the depth of tumour invasion. 
Likewise ogawaet al66 reported higher stromal CD10 expression in more invasive 
tumour.In contrast to the observations made in the present study, jang et al in 2013 
concluded that there was no correlation between CD10expression and depth of tumour 
invasion. 
8. Comparison between Tumour and Stromal CD10 Expression  with gross 
feature 
 In our present study with study group of 30,mean difference of stromal CD 10 
expression in ulceroproliferative growth across the group is statistically significant(p 
value-0.047).Ogawa et al66analyzed the expression of CD10 in the cell stroma and 
showed significantly more positivity in protruding lesion. 
Waisberg et al also reported positivity for CD10 more in exophytic appearance of 
tumour. 
Yao et al67 in 2002 also supported the findings of significant CD 10 positivity high in 
proliferative lesion than in infiltrating lesion. 
9. Comparison between Tumour and Stromal CD10 expression and Nodal status 
of Patient. 
In our study group(N=30), the meandifference between the TUMOURCD10 in 
subjects with Positive nodal status and in subjects with negative nodal status across 
the group is (26.25).  It is statistically   significant (P Value 0.049)  
The meandifference between the STROMAL CD 10 in subjects with positive nodal 
status and in subjects with negative nodal status across the group is 30.38.It is 
statistically significant. 
 Bernescu68 et al conducted a study in 2016 with 191 patients ,cancer stages ranging 
from T1N0 to T3N2  and found CD 10 expression clinically significant in node 
positive cases. 
10. Comparison between Tumour and Stromal CD10 expression and stage of  
colorectal adenocarcinomas :   On comparing the CD10 expression between stage I 
and II adenocarcinomas and stage III adenocarcinomas it was found that the difference 
in mean cd10 expression between the two groups was not  statistically significant 
showing that CD10 expression  does not correlates with the stage of colorectal 
adenocarcinomas.  
Fujita et al in 2007 also showed expression of CD 10 did not show any statististical 
significance with the clinical staging of colorectal adenocarcinoma 
Waisberg et al in 2012 analysed the expression of CD 10 in various stage of colorectal 
carcinoma and found no positive correlation. 
CONCLUSION: 
The aim of the present study was to examine the expression of  CD10, cell membrane 
metallopeptidase  in colorectal neoplasia, its role in the transition sequence from 
adenoma to adenocarcinoma and its association with various clinicopathological 
characters of adenocarcinomas. The following are the conclusions of the present study 
 CD 10 expression showed a significant increase from   adenoma to 
adenocarcinoma. This signifies that  CD10 plays an important role in all stages 
of the adenoma-carcinoma sequence, which includes the early event of 
adenoma formation from normal epithelium and its malignant transformation. 
 The expression of  CD10 showed significant correlation with Depth of tumour 
invasion and nodal status 
 These results highlight the association of  CD 10expression with malignant 
behaviour of colorectal adenocarcinomas and CD10 could prove to be a new 
biomarker for aggressiveness and prognostic information in these tumors. 
 There was however no correlation between CD 10expression and the age and 
tumour stage 
 The finding of gradually increasing  CD 10 expression in adenoma to 
significantly higher expression in adenocarcinomas makes CD 10 an attractive 
and potential therapeutic target, which when implemented will result in 
maximal targeting of  cancerous and also pre cancerous tissues with minimal 
damage to the surrounding normal mucosa. 
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